Prof Eduard VietaClinician
professor of psychiatry at the University of Barcelona and editor in chief of the European College of Neuropsychopharmacology journal
Cited in UK press coverage of health & social care
1 citation
Across 1 topic, first on 27 Aug 2026.
Expertise
Cited on
What they’ve said
“From a clinical perspective, these findings are reassuring regarding the psychiatric safety of GLP-1 receptor agonists and suggest a potential role not only in preventing worsening but also, possibly, in improving mental health outcomes. However, they should not yet be interpreted as evidence of a direct therapeutic effect on depression or anxiety.”
professor of psychiatry at the University of Barcelona and editor in chief of the European College of Neuropsychopharmacology journal · Mental health · 27 Aug 2026 · GLP-1 diabetes drugs could stop anxiety and depression worsening, study finds ↗
Source references
- GLP-1 diabetes drugs could stop anxiety and depression worsening, study findstheguardian.com · 27 Aug 2026
Doctors, nurses, allied health professionals and other registered clinicians quoted in a clinical capacity. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.